- Vial lot
- CJCI-2601
- Same lot as CJCI10-26001 on the certificate
- Tested
- Mar 22, 2026
- Labeled
- 10mg
- Measured
- Ipamorelin 4.07mg · CJC-1295 5.09mg
Akro2603200287freedomdiagnosticstesting.com
Image 1 of 4Research vials only. Discounts and Bundle & Save don't apply to Reconstitution Solution; Subscribe & Save 5% does.
Full termsOriginal laboratory certificate
Akro2603200287freedomdiagnosticstesting.comCJC-1295 + Ipamorelin is a blend of two research peptides: modified GRF(1-29), a growth hormone-releasing hormone (GHRH) analogue sold as CJC-1295 without drug affinity complex (DAC), and ipamorelin, a pentapeptide growth hormone secretagogue (Aib-His-D-2Nal-D-Phe-Lys-NH₂). Ipamorelin's receptor pharmacology was characterised in rat pituitary cells1. No study of the combination is cited here. Supplied for in-vitro research use only.
Made in the USA
Storage Instructions
Storage: Store the sealed vial at −20 °C, protected from light and moisture. Move it to −20 °C on arrival. Shipping: Compounds are stable at ambient temperature for the days to weeks of normal transit, so cold-chain shipping isn't needed. Before opening: Let the sealed vial reach room temperature before opening to prevent condensation.
| Product Name | CJC-1295 + Ipamorelin |
|---|---|
| Format | Lyophilized blend |
| Origin | Made in the USA |
| Intended Use | In-vitro research only; not for human or animal consumption. |
Ipamorelin, the first selective growth hormone secretagogue
Raun K, et al.·Eur J Endocrinol·1998PMID 9849822
View on PubMedThe following references are provided for informational purposes and do not constitute medical advice. AKRO Research products are for research use only — not for human consumption.